New method for quickly testing how bacteria respond to antibiotics
Official title: Exclusive liquid repellency enables next-generation phenotypic antimicrobial susceptibility testing
Funded at University of Wisconsin-Madison · NIH-11095992 · Data updated 2026-11-12
This study is working on a faster way to test how well antibiotics can fight bacteria in patients, like those with infections in their blood or urine, so doctors can quickly find the right treatment for you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project start | June 3, 2024 |
| Project end | April 30, 2029 |
| Funding year | 2025 |
| Award (this year) | $763,028 |
| NIH project number | 5R01AI184593-02 |
| Project ID | NIH-11095992 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients with bacterial infections who require timely and accurate antibiotic susceptibility testing.
✕Less likely to help
Patients with viral infections or those who do not have a bacterial infection may not benefit from this research.
What this research studies
This research focuses on developing a new system for antimicrobial susceptibility testing (AST) that can rapidly identify how bacteria from patients respond to antibiotics. By using an innovative liquid repellency technique, the study aims to streamline the testing process, allowing for quicker and more accurate results without the need for lengthy culture methods. This approach will directly test clinical samples, such as blood or urine, to provide timely treatment options for patients with bacterial infections. The research involves a collaborative team of experts from various fields, including microbiology and bioengineering.
Why it matters
Potential benefit: If successful, this research could lead to faster and more effective treatment options for patients with bacterial infections, reducing the risk of antibiotic resistance.
How similar studies have gone: Previous research has shown promise in improving antimicrobial susceptibility testing methods, but this specific approach using exclusive liquid repellency is novel.
Where this research is happening
-
University of Wisconsin-Madison
Madison, United States Active
Researchers
- Principal investigator: Rose, Warren E — University of Wisconsin-Madison
- Study coordinator: Rose, Warren E
Related research
Other NIH-funded projects on the same topics.
-
BRAVE Innovation Center for Viral Resistance in Chickens
A center at UW–Madison aims to create chickens genetically resistant to avian viruses like H5N1 by identifying host genes involved in virus replication using genome-wide CRISPR screening.
-
Center to Fight Vector-Borne Diseases in the Midwest
A Midwest program brings researchers, public health teams, and vector-control groups together to prevent diseases spread by ticks and mosquitoes.
-
Globally useful predictor for cervical cancer treatment response
This project aims to develop a simple predictive signature to personalize treatment for locally advanced cervical cancer using easy tests and imaging.
-
Neutrophil development with stem cells to understand their behavior
Researchers are studying how neutrophils, a type of immune cell, develop from stem cells to better understand why they can help or harm in infections and inflammatory diseases.
-
WREN: Expanding Research Capacity in Rural Primary Care Clinics
A nationwide network in Wisconsin will strengthen rural primary care clinics to participate in real-world research and bring more clinical trials to communities.
-
Targeting early oral GVHD to improve mouth health after stem cell transplant
A study at UW–Madison will explore why some transplant patients develop painful oral GVHD and test ideas to prevent and lessen mouth-related problems.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.